Aerogen is a world leader in acute care aerosol drug delivery†1
The Aerogen Ultra is a handheld device that is used in conjunction with the Aerogen Solo to deliver inhalation treatment either post-ventilation as part of the weaning process or during exacerbations.
†Global market presence in 75+ countries worldwide
- Oxygen port enables optional delivery of oxygen2
- An ergonomic valved mouthpiece controls the flow of air through the chamber to facilitate aerosol drug delivery2
- Innovative chamber design provides an aerosol reservoir intended for optimal drug delivery2
- Extended mouthpiece‡ to easily add bacterial or viral filter2
‡The Aerogen Ultra with an extended mouthpiece is only available in selected regions. In countries where an extended mouthpiece is not available, an adapter can be used.
Effectiveness
Aerogen Ultra facilitates effective medication delivery during self-ventilation3–6
In studies, bronchodilator administration via the Aerogen Ultra was associated with:
- 6x more medication delivered to the lungs during self-ventilation versus a jet nebuliser3
- Significantly less medication left in the cup versus other nebulisers2,‡4
†Study performed in healthy subjects; between-group difference: 34.1% vs 5.2%; p<0.001
‡In-vitro/ex vivo models
Patient care
Aerogen Ultra improves patient care in response to aerosolised medication5,6
In studies, when compared with jet nebulisers, bronchodilator administration via Aerogen Ultra was associated with:
In children with a moderate-to-severe asthma exacerbation:
- Significantly fewer treatments and significantly less time required to achieve symptom control†5
- 30% relative reduction in hospital admission rates6
- 85% of patients achieving symptom control with one 2.5 mg salbutamol dose6
- 37-minute reduction in ED median length of stay6
†Defined as achieving a mild asthma score following an asthma exacerbation
Workflow
Aerogen simplifies the workflow
- Aerogen is intended for the aerosolisation of any physician-prescribed solutions for inhalation2
- One system used throughout a patient's respiratory journey (IMV, NIV, HF, self-ventilating),2 supporting continuity of care
- Virtually silent delivery,2 keeping a calm environment for your patients
- No added flow2
How it works
The core of Aerogen’s success is a unique palladium vibrating mesh creating optimal particle size for delivering inhaled medication into the lungs1.
Enquiries
The Aerogen team and our representatives are available globally to answer your questions, provide an online demonstration and place orders
- Aerogen data on file
- Aerogen Solo Instruction Manual
- Dugernier J, Hesse M, Vanbever R, et al. Pharm Res. 2017;34(2):290-30.
- Lin H-L, Fang T–P, Cho H-S, et al. Pulm Pharmacol Ther. 2018;48:225-231.
- Moody GB, Luckett PM, Shockley CM, et al. Respir Care 2020;65(10):1451–1463.
- Dunne RB, Shortt S. Am J Emerg Med. 2018;36(4):641-646.
GL1219A09-22
